Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
China · Delayed Price · Currency is CNY 5.85
-0.09 (-1.52%)
Nov 6, 2026, 10:25 AM CST
SHE:300942 Market Cap
SHE:300942 has a market cap or net worth of 2.37 billion as of November 5, 2026. It is the 16,827th most valuable company in the world and the 4,546th biggest in China. Its market cap has decreased by 47.34% in one year.
Market Cap
2.37B
Enterprise Value
2.29B
Revenue
280.69M
Global Rank
Country Rank
#4,546 China
PE Ratio
n/a
ChartMarket Cap Chart
Since February 9, 2021, SHE:300942's market cap has decreased from 14.45B to 2.37B, a decrease of -83.60%. That is a compound annual growth rate of -27.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 2.37B | -37.83% |
| Dec 31, 2025 | 3.81B | 10.95% |
| Dec 31, 2024 | 3.44B | -26.69% |
| Dec 29, 2023 | 4.69B | -31.80% |
| Dec 30, 2022 | 6.87B | -40.61% |
| Dec 31, 2021 | 11.57B | -19.92% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hubei Goto Biopharm Group | 2.84B |
| Zhejiang Shouxiangu Pharmaceutical | 2.75B |
| Beijing Kawin Technology Share-Holding | 2.75B |
| Landfar Bio-medicine | 2.73B |
| Guangdong VTR Bio-Tech | 2.59B |
| Shanghai Universal Biotech | 2.56B |
| Yantai Zhenghai Biotechnology | 2.54B |
| Zhejiang East Asia Pharmaceutical | 2.39B |